Sensorium Reports Positive Phase 1a Data for SNTX-2643
Cambridge, Massachusetts, U.S., September 21, 2026 Sensorium Therapeutics, a clinical-stage central nervous system biotechnology company, has announced positive Phase...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts, U.S., September 21, 2026 Sensorium Therapeutics, a clinical-stage central nervous system biotechnology company, has announced positive Phase...
Pleasanton, California, U.S., September 21, 2026 Veeva Systems has introduced Veeva Falcon Router, an agentic artificial intelligence solution designed...
Germantown, Maryland, U.S., September 21, 2026 Precigen has announced that the U.S. Food and Drug Administration (FDA) has granted...
Sarasota, Florida, September 18, 2026 Lakewood-Amedex Biotherapeutics Inc. has announced that it has received central and all clinical-site Institutional...
LIBERTY CORNER, N.J. — September 17, 2026 Lisata Therapeutics announced the acquisition of Marea Therapeutics, combining the companies to...
SOUTH SAN FRANCISCO, Calif. — September 17, 2026 Dualitas Therapeutics announced a research collaboration and license agreement with Roche...
Waltham, Massachusetts, USA, September 17, 2026 Nona Biosciences has announced the successful development of what it describes as the...
United States, September 17, 2026 SMSbiotech has announced that the U.S. Food and Drug Administration (FDA) has cleared its...
Brisbane, California, USA, September 15, 2026 Vera Therapeutics has announced final efficacy results from the Phase 3 ORIGIN 3...
SOUTH SAN FRANCISCO, Calif. — September 16, 2026 Twist Bioscience Corporation announced an agreement with Lilly TuneLab, the collaborative...
